The Hunt for an Autism Drug

Victor
By -
0
Just read an interesting article in Business Week ("The Hunt for an Autism Drug") about how many companies are seeking drugs to treat autism. Apparently, 1 in 110 8-year old children in the US falls someone on the autism scale. That's a pretty staggering statistic when you think about it. Obviously autism is a very different disease from Crohn's, so why am I mentioning this? When I was reading the book Breaking the Vicious Cycle, they mentioned how the Specific Carbohydrate Diet showed improvement in children with autism. One start-up drug maker is looking at this link:
One of the most promising treatments in this category is a drug called CM-AT made by a startup called Curemark. Dr. Joan Fallon, the company's founder and CEO, observed that many autistics show a strong preference for foods high in carbohydrates and low in protein. A diagnostic test revealed that some autistic children lack enzymes that digest protein. As a result, these children produce fewer of the essential amino acids that are the building blocks for brain development and neuroreception. Fallon believes this deficiency is linked to the most severe symptoms of autism, and she says an early observational study of CM-AT, an orally ingested powder that delivers protein-digesting protease, showed "significant improvements." Curemark is enrolling patients in phase III clinical trials at 10 to 12 sites—the largest autism trial to date.
Seemed related and interesting so thought I would mention it.

The other thing I found interesting was the mention of epigenetics, which I think I'm going to do some further research on. The basic premise is that the environment can influence gene expression. So many diseases may be a combination of both genetics and environmental influences (pollution, viruses, diet, etc.). Perhaps that's why it is so hard to pin down a single cause for Crohn's, autism, and many other diseases.

Post a Comment

0Comments

Post a Comment (0)